###begin article-title 0
SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 667 668 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 718 726 718 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 960 963 960 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1052 1055 1052 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
Mechanisms of gene repression by transforming growth factor-beta (TGF-beta) are not well understood. TGF-beta represses transcription of pulmonary surfactant protein-B gene in lung epithelial cells. Repression is mediated by SMAD3 through interactions with NKX2.1 and FOXA1, two key transcription factors that are positive regulators of SpB transcription. In this study, we found that SMAD3 interacts through its MAD domains, MH1 and MH2 with NKX2.1 and FOXA1 proteins. The sites of interaction on NKX2.1 are located within the NH2 and COOH domains, known to be involved in transactivation function. In comparison, weaker interaction of FOXA1 winged helix, and the NH2-terminal domains was documented with SMAD3. Both in vitro studies and in vivo ChIP assays show that interaction of SMAD3 MH1 and MH2 domains with NKX2.1 and FOXA1 results in reduced binding of NKX2.1 and FOXA1 to their cognate DNA-binding sites, and diminished promoter occupancy within the SpB promoter. Thus, these studies reveal for the first time a mechanism of TGF-beta-induced SpB gene repression that involves interactions between specific SMAD3 domains and the corresponding functional sites on NKX2.1 and FOXA1 transcription factors.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Transforming growth factors-beta (TGF-beta) are a large family of secreted polypeptides with established roles in nearly every aspect of cellular physiology, pathology and tumorigenesis. In the lung, as in other organs, TGF-beta regulates tissue morphogenesis and cellular differentiation through regulation of target gene expression (1). Although regulation of gene expression by TGF-beta is complex, from a simplistic perspective, the binding of TGF-beta ligand to its receptors, TbetaRII and TbetaRI initiates a cascade of phosphorylation events that eventually result in nuclear translocation of SMAD2 and SMAD3 subsequent to their association with SMAD4. To date, much has been elucidated regarding the mechanisms of TGF-beta-induced gene activation. However, TGF-beta also inhibits gene transcription and comparatively much less is known about the latter mechanism.
###end p 4
###begin p 5
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 743 746 743 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 792 793 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 273 279 <span type="species:ncbi:9606">humans</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 487 493 <span type="species:ncbi:9606">humans</span>
###xml 498 513 <span type="species:ncbi:10090">transgenic mice</span>
Surfactant protein-B, SPB is a protein constituent of pulmonary surfactant, a surface-active material that stabilizes lung alveoli and is therefore critical to air breathing. As a key component of pulmonary surfactant, SPB is absolutely required for postnatal survival. In humans, inherited SPB deficiency is a lethal condition that requires lung transplantation. Targeted inactivation of SpB in mouse also causes perinatal lethality (2). Even reduced SPB perturbs lung function in both humans and transgenic mice (3,4). Increased bioactive TGF-beta is associated with a number of pathological lung conditions, including interstitial lung fibrosis (5,6) and bronchopulmonary dysplasia, BPD (7). TGF-beta was found to inhibit the expression of SpB, but the precise mechanism remained unknown (8).
###end p 5
###begin p 6
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 738 741 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpC</italic>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1097 1100 1097 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1120 1122 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1259 1262 1259 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1269 1271 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Expression of SpB is dependent on the activity of a number of transcription factors. The role of the homeodomain transcription factor NKX2.1, (otherwise known as TTF-1 or TEBP) is central, illustrated by the observation that in Nkx2.1(-/-) embryonic lungs SpB gene activity is entirely lacking (9). Many signaling cues during lung development or in response to injury are mediated through physical and functional interactions of NKX2.1 with other nuclear factors. These interactions modulate the activity of NKX2.1 on its target gene promoters. For example, NKX2.1 interacts with the nuclear factors, TAZ (a transcriptional co-activator with PDZ-binding domain) and NFI (nuclear Factor I) to activate transcription from the lung-specific SpC gene (10,11). TAZ interacts with the amino-terminal domain of NKX2.1 increasing its transcription activation properties. The 5' flanking region of the SpB gene also includes binding sites for members of the forkhead/winged helix transcription factors, FOXA1/FOXA2. In transient transfection studies, the latter binding sites were found to be critical for SpB promoter activity (12). Compound genetic disruption of Foxa1/Foxa2 loci eliminates epithelial cell differentiation and consequently results in the absence of SpB mRNA (13).
###end p 6
###begin p 7
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 149 151 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 201 204 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 281 284 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 365 368 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 712 715 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1115 1118 1112 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
Previously, we showed that TGF-beta repression of SpB transcription in lung epithelial cells occurs through TbetaRI signaling and mediated by SMAD3 (14). No evidence for direct binding of SMAD3 to the SpB promoter was found, and a DNA-binding mutant of SMAD3 effectively repressed SpB, eliminating direct DNA-binding requirement. Mutations within a 70 bp domain of SpB promoter that includes binding sites for NKX2.1 and FOXA proteins eliminated SMAD3-dependent repression of transcription. Further studies suggested interactions between SMAD3 and both NKX2.1 and FOXA1 proteins. We therefore proposed that SMAD3 interactions with NKX2.1 and FOXA1 underlie the molecular basis for TGF-beta-induced repression of SpB transcription. In the present study, we have elucidated the precise nature and the sites of interaction between SMAD3 and the two transcription factors NKX2.1 and FOXA1 using a number of experimental approaches. The sum of the results show that interaction of SMAD3 occurs through the MH1 and MH2 domains of SMAD3 and lead to inhibition of NKX2.1 and FOXA1 binding to their cognate sites within the SpB promoter.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Plasmid construction
###end title 9
###begin p 10
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa1</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa2</italic>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa1</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa2</italic>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 381 403 381 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Foxa1, Vp16-Foxa2</italic>
###xml 408 419 408 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Nkx2.1</italic>
###xml 434 475 434 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Foxa1N, Vp16-Foxa1DB and Vp16-Foxa1C</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa1</italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pVp16</italic>
###xml 747 782 747 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1. Gal4-Nkx2.1N, Gal4-Nkx2.1HD</italic>
###xml 787 799 787 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-Nkx2.1C</italic>
###xml 841 847 841 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 999 1001 999 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pM</italic>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
###xml 37 40 <span type="species:ncbi:10116">rat</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Complete coding region of rat Foxa1, rat Foxa2 and human Nkx2.1 were PCR amplified from cDNA clones (a gift from Dr Costa, University of Illinois at Chicago) verified by sequencing and cloned into EcoRI and BamHI sites (for Foxa1 and Foxa2) or EcoRI and HindIII sites (for Nkx2.1), in translational frame with VP16 coding region of pVp16 vector (Clontech, CA, USA), and designated Vp16-Foxa1, Vp16-Foxa2 and Vp16-Nkx2.1 respectively. Vp16-Foxa1N, Vp16-Foxa1DB and Vp16-Foxa1C were constructed by cloning the specific Foxa1 fragments that encodes amino acids 1-137, amino acids 138-317 and amino acids 318-466, into EcoRI and BamHI sites of pVp16. Similar strategy was used for making GAL4 fusion constructs containing specific domain fragments of Nkx2.1. Gal4-Nkx2.1N, Gal4-Nkx2.1HD and Gal4-Nkx2.1C were constructed by cloning the specific Nkx2.1 fragments that encodes amino acids 1-141, amino acids 142-253 and amino acids 254-371, into EcoRI and BamHI, BamHI and MluI, MluI and HindIII sites of pM (Clontech, CA, USA), respectively.
###end p 10
###begin p 11
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-Smad3, Vp16-Smad3</italic>
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST-Smad3</italic>
###xml 128 160 128 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-MH1, Gal4-MH2 and Gal4-LNKR</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Gal4-Smad3, Vp16-Smad3 and glutathione-S-transferase, GST-Smad3 were provided by Dr R. Derynck (UCSF, CA, USA). Construction of Gal4-MH1, Gal4-MH2 and Gal4-LNKR have been described (15).
###end p 11
###begin title 12
Cell culture and transient transfection assays
###end title 12
###begin p 13
###xml 683 685 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 151 157 <span type="species:ncbi:9913">bovine</span>
The human pulmonary epithelial cell lines A549 and H441 were maintained in F-12K Nutrient Mixture (Amersham Biosciences, NJ, USA) containing 10% fetal bovine serum and 1% penicillin-streptomycin. All plasmids used in transfection studies were purified on QIAGEN columns (Qiagen, CA, USA). Transient transfection of A549 cells was performed with SuperFect as described by the manufacturer (Qiagen, CA). After transfection, cells were lyzed and the extracts were collected as described (Promega, WI, USA). Supernatants of the cell extracts were used for assay of beta-galactosidase and luciferase as described by the manufacturer (Promega, WI). MLE15 cells were cultured as described (16) and used for extracting nuclear protein for EMSA.
###end p 13
###begin title 14
Mammalian two-hybrid assay
###end title 14
###begin p 15
###xml 164 172 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-Lux</italic>
###xml 188 195 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pFR-Luc</italic>
###xml 213 216 201 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pSV</italic>
###xml 222 225 207 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gal</italic>
###xml 496 498 481 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pM</italic>
###xml 503 508 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pVp16</italic>
Expression constructs for GAL4-fusion protein (1.125 microg) and VP16-fusion protein (5.625 microg) were cotransfected with the GAL4-luciferase reporter constructs Gal4-Lux (3.375 microg, pFR-Luc, Stratagene) and pSV-beta-gal (Promega, WI) into A549 cells. The interaction between GAL4-fusion proteins and VP16-fusion protein as indicated in each experiment was measured as a function of transactivation of the heterologous GAL4 promoter as quantified by luciferase production. Vectors including pM and pVp16 (Clontech, CA), were used in transfection experiments as control for GAL4-fusion protein and VP16-fusion protein.
###end p 15
###begin title 16
Oligonucleotides
###end title 16
###begin p 17
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 427 429 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 449 451 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 513 515 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 696 698 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 755 757 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Synthetic oligonucleotides were annealed and diluted as described (12) and used directly in EMSA as cold competitor. For use as probe in EMSA reactions, the annealed oligonucleotides were purified by gel electrophoresis on 3% low melting agarose (Promega, WI), excised and then eluted using QIAEXII (Qiagen, CA). Two picomoles of the purified, annealed oligonucleotides were end-labeled with T4 polynucleotide kinase and gamma-33P-ATP as described (14). The labeled probes were purified from unincorporated gamma-33P-ATP using G-25 Sephadex column (Roche Applied Science, IN, USA). The DNA sequence of the oligonucleotides are as follows. For NKX2.1 binding: 5'-CAC CTG GAG GGC TCT TCA GAG C-3' (12). For FOXA1 binding: 5'-CAA AGA CAA ACA CTG AGG TCG-3' (12).
###end p 17
###begin title 18
Electrophoretic mobility shift assay (EMSA)
###end title 18
###begin p 19
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 147 149 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 611 613 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
Nuclear extracts were prepared from MLE15 cells using a mini-extraction procedure (12). Five micrograms of the nuclear extract were incubated with 33P-end-labeled oligonucleotide probe with or without cold competitor in 12.5 mM Tris-HCl (pH 7.5), 62.5 mM NaCl, 0.62 mM DTT, 10% glycerol, 0.05% NP-40, 0.05 microg/microl Poly(dI-dC) in a total volume of 20 microl at 4degreesC for 15 min. For experiments with antibody or GST fusion proteins, 4 microl antibody or 4.8 microg GST fusion protein were mixed with the nuclear extracts in reaction mixture and incubated at 4degreesC for 15 min before addition of the 33P-end-labeled probe. Bound and free probes were separated by gel electrophoresis on a 4.5% non-denaturing polyacrylamide gel. The NKX2.1 antibody was purchased from Lab Vision Corporation (CA, USA). The FOXA1 antibody was purchased from (CeMines, Co, USA).
###end p 19
###begin title 20
Glutathione-S-transferase (GST) fusion protein purification
###end title 20
###begin p 21
###xml 12 28 12 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 12 28 <span type="species:ncbi:562">Escherichia coli</span>
Cultures of Escherichia coli were transformed with plasmids expressing either GST or GST-SMAD3 fusion proteins. Recombinant proteins were isolated by ultra-sonication, followed by purification using Bulk GST purification module as described by the manufacturer (Amersham Biosciences, NJ, USA).
###end p 21
###begin title 22
Co-immunoprecipitation and western blotting
###end title 22
###begin p 23
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
###xml 754 759 <span type="species:ncbi:10090">mouse</span>
###xml 859 865 <span type="species:ncbi:9986">rabbit</span>
###xml 909 915 <span type="species:ncbi:9986">rabbit</span>
###xml 951 957 <span type="species:ncbi:9986">rabbit</span>
Co-immunoprecipitation was performed as previously described (14). Briefly, proteins were extracted from H441 cells transfected with expression of the appropriate construct and incubated with antibody against NKX2.1, FOXA1 or FLAG (SMAD3-fusion). The Protein G beads (Roche Applied Science, IN, USA) were washed and added to the reaction mixture. After incubation for 1 h at 4degreesC on a rotator, the beads were washed thoroughly and resuspended in 2x reducing loading buffer (Active Motif, CA, USA) for western blot analysis. As negative control, a parallel reaction was performed without the inclusion of the antibody. Antibodies used for immunoprecipitation were mouse anti-FLAG (Sigma, MI), mouse anti-NKX2.1 (Lab Vision Corporation, CA, USA), and mouse anti-FOXA1 (Seven Hills Bioreagents, OH, USA) antibodies. Western blots were performed with either rabbit anti-NKX2.1 (Seven Hills Bioreagents, OH), rabbit anti-FOXA1 (CE Mines, CO, USA), or rabbit anti-SMAD3 (Abcam, MA, USA) antibodies.
###end p 23
###begin title 24
Chromatin immunoprecipitation assay (ChIP)
###end title 24
###begin p 25
###xml 1552 1555 1482 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1786 1788 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
ChIP assays were performed using a ChIP-ITtrade mark kit (Active Motif, Inc., Carlsbad, CA, USA) following the manufacturer's instructions. Unless otherwise stated, all reagents, buffers and supplies were included in the kit. Briefly, MLE15 cells were cross-linked with 1% formaldehyde for 10 min at room temperature. After washing and treatment with glycine Stop-Fix solution, the cells were resuspended in lysis buffer and incubated for 30 min on ice. The cells were homogenized and nuclei were resuspended in shearing buffer and subjected to optimize enzymatic shearing conditions to yield 100-400 bp DNA fragments. The chromatin was pre-cleared with protein G beads and incubated (overnight at 4degreesC) with 3 microg of negative control mouse IgG (provided in the ChIP-ITtrade mark kit) and anti-NKX2.1 polyclonal antibody (Seven Hills Bioreagents, Cincinnati, OH). Protein G beads were then added to the antibody/chromatin incubation mixtures and incubated for 1.5 h at 4degreesC. After extensive washings, the immunoprecipitated DNA was removed from the beads in an elution buffer. To reverse cross-links and remove RNA, 5 M NaCl and RNase were added to the samples and incubated for 4 h at 65degreesC. The samples were then treated with proteinase K for 2 h at 42degreesC, and the DNA was purified using DNA purification mini-columns. The purified DNA was subjected to PCR amplification (1 cycle of 94degreesC for 3 min, 35 cycles of 94degreesC for 20 s, 58degreesC for 30 s and 72degreesC for 30 s). For assessment of NKX2.1 occupancy of the SpB promoter, the primers used in PCR were: ATT TGA CGG TGA ACA AAG TCA GGC T (forward for NKX2.1 and FOXA1-binding sites); GAC CTC AGT GTT TGC CTG TGT CT (reverse for NKX2.1); and TCT TAT AGT AGG GGA GAG GAC CTG (reverse for FOXA1) (17).
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
SMAD3 interacts with FOXA1& NKX2.1 in a mammalian two-hybrid assay
###end title 27
###begin p 28
###xml 363 378 363 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-luciferase</italic>
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 654 669 654 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-luciferase</italic>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 904 912 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1049 1058 1049 1058 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1093 1094 1093 1094 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1128 1129 1128 1129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1220 1243 1220 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Nkx2.1, Vp16-Foxa1</italic>
###xml 1247 1257 1247 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Foxa2</italic>
###xml 1407 1411 1407 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 1416 1420 1416 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 1460 1497 1460 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2</italic>
###xml 1655 1656 1655 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1058 1664 1058 1664 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="29">SMAD3 interacts with NKX2.1 (Panel <bold>A</bold>) and both FOXA1 and FOXA2 (Panel <bold>B</bold>) in lung epithelial cells. Mammalian two-hybrid assays were performed in A549 cells using <italic>Vp16-Nkx2.1, Vp16-Foxa1</italic> or <italic>Vp16-Foxa2</italic> expression plasmids according to the protocol described in Materials and Methods section. Luciferase readings from the controls consisting of, empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids alone, or in combination with <italic>Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2</italic> were adjusted to unity and used to normalize all experimental results. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p>
###xml 1058 1664 1058 1664 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="29">SMAD3 interacts with NKX2.1 (Panel <bold>A</bold>) and both FOXA1 and FOXA2 (Panel <bold>B</bold>) in lung epithelial cells. Mammalian two-hybrid assays were performed in A549 cells using <italic>Vp16-Nkx2.1, Vp16-Foxa1</italic> or <italic>Vp16-Foxa2</italic> expression plasmids according to the protocol described in Materials and Methods section. Luciferase readings from the controls consisting of, empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids alone, or in combination with <italic>Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2</italic> were adjusted to unity and used to normalize all experimental results. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption>
###xml 1664 1664 1664 1664 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f1"/>
###xml 1049 1664 1049 1664 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="29">SMAD3 interacts with NKX2.1 (Panel <bold>A</bold>) and both FOXA1 and FOXA2 (Panel <bold>B</bold>) in lung epithelial cells. Mammalian two-hybrid assays were performed in A549 cells using <italic>Vp16-Nkx2.1, Vp16-Foxa1</italic> or <italic>Vp16-Foxa2</italic> expression plasmids according to the protocol described in Materials and Methods section. Luciferase readings from the controls consisting of, empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids alone, or in combination with <italic>Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2</italic> were adjusted to unity and used to normalize all experimental results. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm871f1"/></fig>
A mammalian two-hybrid assay in the lung carcinoma, A549 cell line was used to determine physical interactions between SMAD3 and NKX2.1 or FOXA1. Accordingly, a construct expressing GAL4-fused-SMAD3 was transiently cotransfected with another construct that expresses a VP16-fused-NKX2.1 protein and the interactions were monitored by luciferase production from a Gal4-luciferase reporter construct (Figure 1, Panel A). In a separate set of experiments, we used VP16-fused-FOXA1 to determine its interactions with SMAD3 (Figure 1, Panel B). In both sets of studies SMAD3 interacted physically with either NKX2.1 or FOXA1 to bring about stimulation of the Gal4-luciferase reporter construct. FOXA1 and FOXA2 are nearly 93% identical in their primary structure (18). Using a VP16-FOXA2 fusion protein in a mammalian two-hybrid assay showed that FOXA2 also interacts with SMAD3 in a similar manner as FOXA1 (Figure 1, Panel B). The above results clearly indicated physical and robust interactions between FOXA1, NKX2.1 and the TGF-beta-activated SMAD3. Figure 1.SMAD3 interacts with NKX2.1 (Panel A) and both FOXA1 and FOXA2 (Panel B) in lung epithelial cells. Mammalian two-hybrid assays were performed in A549 cells using Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2 expression plasmids according to the protocol described in Materials and Methods section. Luciferase readings from the controls consisting of, empty Vp16 and Gal4 plasmids alone, or in combination with Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2 were adjusted to unity and used to normalize all experimental results. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 28
###begin p 29
###xml 35 36 35 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 162 185 162 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Nkx2.1, Vp16-Foxa1</italic>
###xml 189 199 189 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Foxa2</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 402 439 402 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2</italic>
###xml 597 598 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
SMAD3 interacts with NKX2.1 (Panel A) and both FOXA1 and FOXA2 (Panel B) in lung epithelial cells. Mammalian two-hybrid assays were performed in A549 cells using Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2 expression plasmids according to the protocol described in Materials and Methods section. Luciferase readings from the controls consisting of, empty Vp16 and Gal4 plasmids alone, or in combination with Vp16-Nkx2.1, Vp16-Foxa1 or Vp16-Foxa2 were adjusted to unity and used to normalize all experimental results. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 29
###begin p 30
###xml 500 508 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 711 719 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1367 1375 1363 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1386 1394 1382 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1397 1406 1393 1402 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1461 1462 1457 1458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1481 1482 1477 1478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1689 1692 1685 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1406 1947 1402 1943 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31">EMSA analysis of SMAD3 interactions with NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>). A representative EMSA showing the results of an experiment with nuclear extracts from MLE15 cells to analyze nucleoproteins bound to an oligonucleotide of the binding sites for NKX2.1 or FOXA1 within the <italic>SpB</italic> promoter. Please note supershifted complex with either NKX2.1 or FOXA1 antibodies in Lane 3, Panel A and Lane 3 Panel B, respectively (arrows). In panel A, increasing amounts of GST-SMAD3 were used to examine the effect on the binding affinity of NKX2.1.</p>
###xml 1406 1947 1402 1943 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="31">EMSA analysis of SMAD3 interactions with NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>). A representative EMSA showing the results of an experiment with nuclear extracts from MLE15 cells to analyze nucleoproteins bound to an oligonucleotide of the binding sites for NKX2.1 or FOXA1 within the <italic>SpB</italic> promoter. Please note supershifted complex with either NKX2.1 or FOXA1 antibodies in Lane 3, Panel A and Lane 3 Panel B, respectively (arrows). In panel A, increasing amounts of GST-SMAD3 were used to examine the effect on the binding affinity of NKX2.1.</p></caption>
###xml 1947 1947 1943 1943 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f2"/>
###xml 1397 1947 1393 1943 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="31">EMSA analysis of SMAD3 interactions with NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>). A representative EMSA showing the results of an experiment with nuclear extracts from MLE15 cells to analyze nucleoproteins bound to an oligonucleotide of the binding sites for NKX2.1 or FOXA1 within the <italic>SpB</italic> promoter. Please note supershifted complex with either NKX2.1 or FOXA1 antibodies in Lane 3, Panel A and Lane 3 Panel B, respectively (arrows). In panel A, increasing amounts of GST-SMAD3 were used to examine the effect on the binding affinity of NKX2.1.</p></caption><graphic xlink:href="gkm871f2"/></fig>
To verify the two-hybrid assay data, we further examined the impact of interactions of bacterially expressed and purified glutathione-S-transferase, GST-fused-SMAD3 on the binding of NKX2.1 and FOXA1 to their cognate-binding sites by EMSA. Using MLE15 nuclear extracts, we examined the binding of nuclear proteins to a 22 bp oligonucleotide representing the cognate-binding site for NKX2.1 (Materials and Methods section). This analysis showed the formation of at least four nucleoprotein complexes (Figure 2, Panel A, Lane 1). Incubation of the nuclear extract with an unlabeled oligonucleotide that has identical DNA sequence to that of the probe competed effectively for the formation of the four complexes (Figure 2, Panel A, Lane 2), whereas inclusion of a monoclonal anti-NKX2.1 antibody in the reaction mixture supershifted a complex as designated by the arrow (Lane 3). Inclusion of a bacterially expressed and purified GST-fused-SMAD3 protein competed, in a dose-dependent manner for the formation of all four complexes, but particularly the larger complexes (lanes 5-7). Importantly in the control reaction, 3.5 microg of GST protein alone had no impact on the formation of any of the four complexes (Lane 4). These results clearly show that GST-SMAD3 protein interferes, in a dose-dependent manner, with the binding of NKX2.1 to its target sequences under in vitro settings (Figure 2). Figure 2.EMSA analysis of SMAD3 interactions with NKX2.1 (Panel A) and FOXA1 (Panel B). A representative EMSA showing the results of an experiment with nuclear extracts from MLE15 cells to analyze nucleoproteins bound to an oligonucleotide of the binding sites for NKX2.1 or FOXA1 within the SpB promoter. Please note supershifted complex with either NKX2.1 or FOXA1 antibodies in Lane 3, Panel A and Lane 3 Panel B, respectively (arrows). In panel A, increasing amounts of GST-SMAD3 were used to examine the effect on the binding affinity of NKX2.1.
###end p 30
###begin p 31
###xml 55 56 55 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
EMSA analysis of SMAD3 interactions with NKX2.1 (Panel A) and FOXA1 (Panel B). A representative EMSA showing the results of an experiment with nuclear extracts from MLE15 cells to analyze nucleoproteins bound to an oligonucleotide of the binding sites for NKX2.1 or FOXA1 within the SpB promoter. Please note supershifted complex with either NKX2.1 or FOXA1 antibodies in Lane 3, Panel A and Lane 3 Panel B, respectively (arrows). In panel A, increasing amounts of GST-SMAD3 were used to examine the effect on the binding affinity of NKX2.1.
###end p 31
###begin p 32
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 161 169 161 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 430 438 430 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 900 908 900 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Similar analyses for FOXA1 using an oligonucleotide representing the cognate FOXA1-binding site on the SpB promoter identified multiple nucleoprotein complexes (Figure 2, Panel B, Lane 1). The formation of the majority of these complexes was inhibited upon inclusion of an unlabeled oligonucleotide (Lane 2). Inclusion of a polyclonal anti-FOXA1 antibody resulted in the formation of a supershifted complex (Lane 3, Arrow). As in Figure 2, Panel A, a recombinant GST protein alone did not compete for the formation of any of the complexes, whereas inclusion of a recombinant GST-SMAD3 fusion protein significantly reduced the formation of the complexes (Lanes 4 and 5, respectively). Dose-dependent inhibition was not conducted for GST-SMAD3 with FOXA1. These data demonstrate that interaction between SMAD3 and FOXA1 reduce the binding of the latter transcription factor to its cognate-binding site in vitro.
###end p 32
###begin title 33
SMAD3 interacts with specific domains of NKX2.1 and FOXA1
###end title 33
###begin p 34
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 263 271 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 561 569 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 657 658 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 866 875 866 875 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1097 1101 1097 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 1105 1109 1105 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 1247 1251 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 1434 1435 1434 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 875 1443 875 1443 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">Physical interactions between SMAD3 and functional domains of NKX2.1. GAL4 or VP16 fused NKX2.1 and its various functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression vectors as control. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p>
###xml 875 1443 875 1443 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="35">Physical interactions between SMAD3 and functional domains of NKX2.1. GAL4 or VP16 fused NKX2.1 and its various functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression vectors as control. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption>
###xml 1443 1443 1443 1443 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f3"/>
###xml 866 1443 866 1443 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="35">Physical interactions between SMAD3 and functional domains of NKX2.1. GAL4 or VP16 fused NKX2.1 and its various functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression vectors as control. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm871f3"/></fig>
To identify the specific domains on the NKX2.1 molecule that mediate the NKX2.1-SMAD3 interactions, we constructed Gal4-fusion plasmids containing one of the three functional domains on the NKX2.1 protein; the NH2-terminus, the homeodomain and the COOH-terminus (Figure 3, Panel A). Each of the latter domains is thought to render distinct roles in transcriptional activation function of NKX2.1. The use of the mammalian two-hybrid assay in A549 cells showed little, if any physical interactions between SMAD3 and the DNA binding, homeodomain region of NKX2.1 (Figure 3, Panel B). In contrast, as evidenced by the level of luciferase production, both the NH2- and the COOH-terminal ends of NKX2.1 interacted strongly with SMAD3 indicating the two regions flanking the NKX2.1 homeodomain to be the sites of interaction involved in inhibition of DNA-binding function. Figure 3.Physical interactions between SMAD3 and functional domains of NKX2.1. GAL4 or VP16 fused NKX2.1 and its various functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Vp16 or Gal4 plasmids were used either alone or in combination with other expression vectors as control. Luciferase reading from combination of empty Vp16 and Gal4 plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 34
###begin p 35
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Physical interactions between SMAD3 and functional domains of NKX2.1. GAL4 or VP16 fused NKX2.1 and its various functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Vp16 or Gal4 plasmids were used either alone or in combination with other expression vectors as control. Luciferase reading from combination of empty Vp16 and Gal4 plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 35
###begin p 36
###xml 122 130 122 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 342 352 342 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Foxa1</italic>
###xml 378 388 378 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16-Smad3</italic>
###xml 392 402 392 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4-Smad3</italic>
###xml 498 506 498 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 843 844 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1052 1060 1052 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1063 1072 1063 1072 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1290 1294 1290 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 1298 1302 1298 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 1442 1446 1442 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 1451 1455 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 1629 1630 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1072 1638 1072 1638 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">Physical interactions between SMAD3 and functional domains of FOXA1. GAL4 or VP16 fused FOXA1 and its functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Empty <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression plasmids as controls. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p>
###xml 1072 1638 1072 1638 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">Physical interactions between SMAD3 and functional domains of FOXA1. GAL4 or VP16 fused FOXA1 and its functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Empty <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression plasmids as controls. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption>
###xml 1638 1638 1638 1638 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f4"/>
###xml 1063 1638 1063 1638 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="37">Physical interactions between SMAD3 and functional domains of FOXA1. GAL4 or VP16 fused FOXA1 and its functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Empty <italic>Vp16</italic> or <italic>Gal4</italic> plasmids were used either alone or in combination with other expression plasmids as controls. Luciferase reading from combination of empty <italic>Vp16</italic> and <italic>Gal4</italic> plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm871f4"/></fig>
Similarly, we determined the functional domains of FOXA1 molecule that are the sites of physical interactions with SMAD3 (Figure 4, Panel A). In order to eliminate spurious artifacts stemming from specific fusion constructs, we generated the SMAD3 constructs as GAL4, rather than VP16-fusion proteins. The results with the full-length FOXA1 (Vp16-Foxa1) were identical, whether Vp16-Smad3 or Gal4-Smad3 fusion constructs were used, thereby validating the results of the mammalian two-hybrid assay. Figure 4, Panel B also shows evidence for physical interaction between SMAD3 and the winged helix DNA-binding domain of FOXA1. In addition, there was measurable interaction between SMAD3 and the transactivation domain of FOXA1 localized to the NH2 terminus. However, this interaction only approached, but did not reach statistical significance (P = 0.071). SMAD3 interaction with the latter two functional domains of FOXA1 was weak when compared to the full-length protein, suggesting that overlapping domains may be required for optimized interactions (Figure 4). Figure 4.Physical interactions between SMAD3 and functional domains of FOXA1. GAL4 or VP16 fused FOXA1 and its functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Empty Vp16 or Gal4 plasmids were used either alone or in combination with other expression plasmids as controls. Luciferase reading from combination of empty Vp16 and Gal4 plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 36
###begin p 37
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vp16</italic>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Physical interactions between SMAD3 and functional domains of FOXA1. GAL4 or VP16 fused FOXA1 and its functional domains were used in mammalian two-hybrid assays to determine the site of interactions with SMAD3. Empty Vp16 or Gal4 plasmids were used either alone or in combination with other expression plasmids as controls. Luciferase reading from combination of empty Vp16 and Gal4 plasmids were adjusted to unity and used for normalization of all experimental values. Representative results from three independent experiments are shown. Asterisks denote P < 0.05.
###end p 37
###begin title 38
SMAD3 domains involved in NKX2.1 and FOXA1 interactions
###end title 38
###begin p 39
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 432 440 432 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 613 621 613 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 720 721 720 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 799 800 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 900 908 900 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1176 1184 1176 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1327 1335 1327 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1663 1671 1663 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1683 1692 1683 1692 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1768 1769 1768 1769 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2126 2127 2126 2127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2226 2229 2226 2229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 2473 2474 2473 2474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1692 2482 1692 2482 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">Localization of SMAD3 functional domains, which interact with NKX2.1. Panel <bold>A</bold>, mammalian two-hybrid assays were used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fused LNKR domains of SMAD3 to interact with a full-length VP16-fused NKX2.1. Empty Gal4 plasmid was used as control and the results were adjusted to unity. All experimental values were normalized against the latter (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with NKX2.1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-NKX2.1 antibody is indicated with an arrow (Lane 3). Please note that inclusion of GST-LNKR in EMSA does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p>
###xml 1692 2482 1692 2482 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">Localization of SMAD3 functional domains, which interact with NKX2.1. Panel <bold>A</bold>, mammalian two-hybrid assays were used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fused LNKR domains of SMAD3 to interact with a full-length VP16-fused NKX2.1. Empty Gal4 plasmid was used as control and the results were adjusted to unity. All experimental values were normalized against the latter (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with NKX2.1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-NKX2.1 antibody is indicated with an arrow (Lane 3). Please note that inclusion of GST-LNKR in EMSA does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption>
###xml 2482 2482 2482 2482 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f5"/>
###xml 1683 2482 1683 2482 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="40">Localization of SMAD3 functional domains, which interact with NKX2.1. Panel <bold>A</bold>, mammalian two-hybrid assays were used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fused LNKR domains of SMAD3 to interact with a full-length VP16-fused NKX2.1. Empty Gal4 plasmid was used as control and the results were adjusted to unity. All experimental values were normalized against the latter (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with NKX2.1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-NKX2.1 antibody is indicated with an arrow (Lane 3). Please note that inclusion of GST-LNKR in EMSA does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm871f5"/></fig>
###xml 2482 2491 2482 2491 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 2566 2567 2566 2567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2775 2779 2775 2779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 2896 2897 2896 2897 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2995 2998 2995 2998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 3258 3259 3258 3259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2491 3267 2491 3267 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">Localization of SMAD3 functional domains, which interact with FOXA1. Panel <bold>A</bold>, mammalian two-hybrid assay was used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fised LNKR domains of SMAD3 to interact with a full-length VP16-fused FOXA1 protein. Results with the empty <italic>Gal4</italic> plasmid were adjusted to unity and used to normalize all experimental values (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with FOXA1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-FOXA1 antibody is indicated with an arrow (Lane 3, and a longer exposure in Lane 9). Please note that only GST-LNKR does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p>
###xml 2491 3267 2491 3267 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">Localization of SMAD3 functional domains, which interact with FOXA1. Panel <bold>A</bold>, mammalian two-hybrid assay was used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fised LNKR domains of SMAD3 to interact with a full-length VP16-fused FOXA1 protein. Results with the empty <italic>Gal4</italic> plasmid were adjusted to unity and used to normalize all experimental values (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with FOXA1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-FOXA1 antibody is indicated with an arrow (Lane 3, and a longer exposure in Lane 9). Please note that only GST-LNKR does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption>
###xml 3267 3267 3267 3267 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f6"/>
###xml 2482 3267 2482 3267 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="41">Localization of SMAD3 functional domains, which interact with FOXA1. Panel <bold>A</bold>, mammalian two-hybrid assay was used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fised LNKR domains of SMAD3 to interact with a full-length VP16-fused FOXA1 protein. Results with the empty <italic>Gal4</italic> plasmid were adjusted to unity and used to normalize all experimental values (Materials and Methods section). Panel <bold>B</bold>, representative EMSA analysis of interactions between various domains of SMAD3 with FOXA1 on the <italic>SpB</italic> promoter. Supershifted nucleoprotein complex with anti-FOXA1 antibody is indicated with an arrow (Lane 3, and a longer exposure in Lane 9). Please note that only GST-LNKR does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkm871f6"/></fig>
Three specific functional domains, which cover the entire SMAD3 molecule were generated as Gal4-fusion constructs. These are the domains in the NH2-terminus (amino acids 1-130), also known as the MH1 domain, the linker domain represented by amino acids 130-230 (LNKR) and the COOH-terminus or MH2 domain (amino acids 230-424). These constructs were then used in a mammalian A549 cell two-hybrid assay with either GAL4-fused-NKX2.1 (Figure 5, Panel A) or GAL4-fused-FOXA1 expression constructs (Figure 6 Panel A). The results showed significant interactions between full-length NKX2.1 and the MH1 domain of SMAD3 (Figure 5). The interaction between NKX2.1 and the SMAD3 MH2 domain did not reach statistical significance (P = 0.083). Little if any interaction was observed with the SMAD3 LNKR domain (P = 0.25). Furthermore, EMSA with GST-fused domains of SMAD3 verified the two-hybrid assay findings (Figure 5, Panel B). Consistent with the two-hybrid results, robust interaction was found between NKX2.1 and the SMAD3 MH1 domain. Weak interaction of NKX2.1 with the MH2 domain was also documented. However, no interaction was observed between LNKR domain of SMAD3 and NKX2.1 (Figure 5, Panel B, Lane 8). In contrast to the interactions with NKX2.1, significant interaction with FOXA1 occurred mainly with the SMAD3 MH2 domain (Figure 6). The two-hybrid assay showed only weak interactions between FOXA1 and either SMAD3 MH1 or LNKR peptides. However, GST-fused-MH1 competed effectively against FOXA1 binding to its target DNA, either indicating the inherent differences between the two techniques or suggesting more complex interactions between the two proteins (Figure 6, Panel B). Figure 5.Localization of SMAD3 functional domains, which interact with NKX2.1. Panel A, mammalian two-hybrid assays were used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fused LNKR domains of SMAD3 to interact with a full-length VP16-fused NKX2.1. Empty Gal4 plasmid was used as control and the results were adjusted to unity. All experimental values were normalized against the latter (Materials and Methods section). Panel B, representative EMSA analysis of interactions between various domains of SMAD3 with NKX2.1 on the SpB promoter. Supershifted nucleoprotein complex with anti-NKX2.1 antibody is indicated with an arrow (Lane 3). Please note that inclusion of GST-LNKR in EMSA does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote P < 0.05.Figure 6.Localization of SMAD3 functional domains, which interact with FOXA1. Panel A, mammalian two-hybrid assay was used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fised LNKR domains of SMAD3 to interact with a full-length VP16-fused FOXA1 protein. Results with the empty Gal4 plasmid were adjusted to unity and used to normalize all experimental values (Materials and Methods section). Panel B, representative EMSA analysis of interactions between various domains of SMAD3 with FOXA1 on the SpB promoter. Supershifted nucleoprotein complex with anti-FOXA1 antibody is indicated with an arrow (Lane 3, and a longer exposure in Lane 9). Please note that only GST-LNKR does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote P < 0.05.
###end p 39
###begin p 40
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 434 435 434 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 534 537 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 781 782 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Localization of SMAD3 functional domains, which interact with NKX2.1. Panel A, mammalian two-hybrid assays were used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fused LNKR domains of SMAD3 to interact with a full-length VP16-fused NKX2.1. Empty Gal4 plasmid was used as control and the results were adjusted to unity. All experimental values were normalized against the latter (Materials and Methods section). Panel B, representative EMSA analysis of interactions between various domains of SMAD3 with NKX2.1 on the SpB promoter. Supershifted nucleoprotein complex with anti-NKX2.1 antibody is indicated with an arrow (Lane 3). Please note that inclusion of GST-LNKR in EMSA does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote P < 0.05.
###end p 40
###begin p 41
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gal4</italic>
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Localization of SMAD3 functional domains, which interact with FOXA1. Panel A, mammalian two-hybrid assay was used to test the ability of GAL4-fused MH1, GAL4-fused MH2 or GAL4-fised LNKR domains of SMAD3 to interact with a full-length VP16-fused FOXA1 protein. Results with the empty Gal4 plasmid were adjusted to unity and used to normalize all experimental values (Materials and Methods section). Panel B, representative EMSA analysis of interactions between various domains of SMAD3 with FOXA1 on the SpB promoter. Supershifted nucleoprotein complex with anti-FOXA1 antibody is indicated with an arrow (Lane 3, and a longer exposure in Lane 9). Please note that only GST-LNKR does not interfere with formation of nucleoprotein complexes (Lane 8). Asterisks denote P < 0.05.
###end p 41
###begin title 42
Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1
###end title 42
###begin p 43
###xml 118 128 118 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad3-Flag</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa1</italic>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 734 742 734 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1196 1204 1196 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1601 1610 1601 1610 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1832 1842 1832 1842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad3-Flag</italic>
###xml 1610 2141 1610 2141 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1. Co-immunoprecipitation with three antibodies, anti-FOXA1, anti-NKX2.1 and anti-FLAG (against Smad3) was performed from extracts of lung carcinoma cells transfected with a <italic>Smad3-Flag</italic> expression construct. The co-IP complexes were analyzed by western blotting using rabbit-derived antibodies to the three target proteins. C = Control (no co-IP antibody), FO = anti-FOXA1 antibody, N = anti-NKX2.1 antibody and FL = anti-FLAG (SMAD3) antibody. The table is a summary of the findings.</p>
###xml 1610 2141 1610 2141 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1. Co-immunoprecipitation with three antibodies, anti-FOXA1, anti-NKX2.1 and anti-FLAG (against Smad3) was performed from extracts of lung carcinoma cells transfected with a <italic>Smad3-Flag</italic> expression construct. The co-IP complexes were analyzed by western blotting using rabbit-derived antibodies to the three target proteins. C = Control (no co-IP antibody), FO = anti-FOXA1 antibody, N = anti-NKX2.1 antibody and FL = anti-FLAG (SMAD3) antibody. The table is a summary of the findings.</p></caption>
###xml 2141 2141 2141 2141 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f7"/>
###xml 1601 2141 1601 2141 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="44">Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1. Co-immunoprecipitation with three antibodies, anti-FOXA1, anti-NKX2.1 and anti-FLAG (against Smad3) was performed from extracts of lung carcinoma cells transfected with a <italic>Smad3-Flag</italic> expression construct. The co-IP complexes were analyzed by western blotting using rabbit-derived antibodies to the three target proteins. C = Control (no co-IP antibody), FO = anti-FOXA1 antibody, N = anti-NKX2.1 antibody and FL = anti-FLAG (SMAD3) antibody. The table is a summary of the findings.</p></caption><graphic xlink:href="gkm871f7"/></fig>
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
###xml 642 648 <span type="species:ncbi:9986">rabbit</span>
###xml 1925 1931 <span type="species:ncbi:9986">rabbit</span>
To further examine the interactions amongst NKX2.1, FOXA1 and SMAD3 proteins, we used co-immunoprecipation (co-IP). A Smad3-Flag expression construct was transfected into H441 cells, which exhibit endogenous Foxa1 and Nkx2.1 gene expression, and the cellular extracts were used for co-IP with mouse anti-FLAG, anti-NKX2.1 and anti-FOXA1 antibodies. We used three antibodies to minimize the possibility of false-negative results stemming from their intrinsic properties that may interfere with protein-protein interactions in co-IP studies. The immunoprecipitated complexes were resolved by gel electrophoresis and western blot analysis using rabbit-derived antibodies to the three proteins. The results are summarized in the table in Figure 7. Anti-FLAG, as expected, immunoprecipitated SMAD3 but also FOXA1, indicating measurable physical interactions by this antibody between SMAD3 and FOXA1, but not NKX2.1. Anti-NKX2.1 immunoprecipitated a complex that included only NKX2.1 and FOXA1, but not SMAD3. Finally, only FOXA1 was brought down by anti-FOXA1 antibodies, even though SMAD3-FOXA1 and NKX2.1-FOXA1 intracellular associations were established by anti-FLAG and anti-NKX2.1 co-IP results (Figure 7). Therefore, failure of anti-FOXA1 to co-immunoprecipitate NKX2.1 or SMAD3, a false-negative result, may be explained by an intrinsic property of this antibody (e.g. its epitope specificity may interfere with protein-protein interactions). Similarly, it is possible that absence of demonstrable NKX2.1-SMAD3 interactions by co-IP may simply be related to specific aspects of the antibodies used. Figure 7.Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1. Co-immunoprecipitation with three antibodies, anti-FOXA1, anti-NKX2.1 and anti-FLAG (against Smad3) was performed from extracts of lung carcinoma cells transfected with a Smad3-Flag expression construct. The co-IP complexes were analyzed by western blotting using rabbit-derived antibodies to the three target proteins. C = Control (no co-IP antibody), FO = anti-FOXA1 antibody, N = anti-NKX2.1 antibody and FL = anti-FLAG (SMAD3) antibody. The table is a summary of the findings.
###end p 43
###begin p 44
###xml 222 232 222 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad3-Flag</italic>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
Co-immunoprecipitation of FOXA1, SMAD3 and NKX2.1. Co-immunoprecipitation with three antibodies, anti-FOXA1, anti-NKX2.1 and anti-FLAG (against Smad3) was performed from extracts of lung carcinoma cells transfected with a Smad3-Flag expression construct. The co-IP complexes were analyzed by western blotting using rabbit-derived antibodies to the three target proteins. C = Control (no co-IP antibody), FO = anti-FOXA1 antibody, N = anti-NKX2.1 antibody and FL = anti-FLAG (SMAD3) antibody. The table is a summary of the findings.
###end p 44
###begin title 45
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
TGF-beta treatment of MLE15 cells reduces the binding of NKX2.1 and FOXA1 to their target genomic sites in vivo
###end title 45
###begin p 46
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 783 791 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 909 917 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1072 1079 1072 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1142 1150 1142 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1289 1292 1289 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1302 1309 1302 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1311 1320 1311 1320 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 1369 1372 1369 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1410 1411 1410 1411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1430 1431 1430 1431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1614 1617 1614 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1320 1830 1320 1830 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Chromatin immunoprecipitation (ChIP) analysis of <italic>SpB</italic> promoter occupancy for NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>) in response to TGF-beta in MLE15 cells. TGF-beta-treated MLE15 nuclear extracts were immunoprecipitated with either anti-NKX2.1 or anti-FOXA1 antibodies and specific regions of the <italic>SpB</italic> promoter (Please see Materials and Methods section) were analyzed by PCR. Arrows indicate the PCR products. Lanes 1 are molecular weight markers. Representative results from two independent experiments are shown.</p>
###xml 1320 1830 1320 1830 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Chromatin immunoprecipitation (ChIP) analysis of <italic>SpB</italic> promoter occupancy for NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>) in response to TGF-beta in MLE15 cells. TGF-beta-treated MLE15 nuclear extracts were immunoprecipitated with either anti-NKX2.1 or anti-FOXA1 antibodies and specific regions of the <italic>SpB</italic> promoter (Please see Materials and Methods section) were analyzed by PCR. Arrows indicate the PCR products. Lanes 1 are molecular weight markers. Representative results from two independent experiments are shown.</p></caption>
###xml 1830 1830 1830 1830 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f8"/>
###xml 1311 1830 1311 1830 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="47">Chromatin immunoprecipitation (ChIP) analysis of <italic>SpB</italic> promoter occupancy for NKX2.1 (Panel <bold>A</bold>) and FOXA1 (Panel <bold>B</bold>) in response to TGF-beta in MLE15 cells. TGF-beta-treated MLE15 nuclear extracts were immunoprecipitated with either anti-NKX2.1 or anti-FOXA1 antibodies and specific regions of the <italic>SpB</italic> promoter (Please see Materials and Methods section) were analyzed by PCR. Arrows indicate the PCR products. Lanes 1 are molecular weight markers. Representative results from two independent experiments are shown.</p></caption><graphic xlink:href="gkm871f8"/></fig>
###xml 253 258 <span type="species:ncbi:9606">human</span>
To examine the in vivo relevance of the studies described above, we performed chromatin immunoprecipitation studies (ChIPs) using nuclear extracts from MLE15 cells. Chromatin fractions were prepared from MLE15 cells treated with and without 10 ng/ml of human recombinant TGF-beta and immunoprecipitated using an anti-NKX2.1 monoclonal antibody and a polyclonal anti-FOXA1 antibody. Subsequent to isolation of DNA from the immunoprecipitate, specific oligonucleotide primers were used to PCR amplify a region of the SpB promoter located between -222 and -74 nt, for the NKX2.1 reaction and -222 and -24 nt, for the FOXA1 reaction. This region includes the binding sites for both NKX2.1 and FOXA1. The experiments were repeated three times with identical results. For NKX2.1 reaction (Figure 8, Panel A), comparison between the intensities of the PCR bands obtained in chromatin prepared from TGF-beta-treated (Figure 8, Panel A, Lane 6) versus untreated (Lane 5) samples supports the concept that TGF-beta treatment diminishes the binding of NKX2.1 to its target sequences in vivo. Similarly, comparison between PCR products in Lanes 5 and 6 (Figure 8, Panel B) clearly shows that treatment of MLE15 cells with TGF-beta ligand diminishes the binding of FOXA1 to its target sequences on the SpB promoter in vivo. Figure 8.Chromatin immunoprecipitation (ChIP) analysis of SpB promoter occupancy for NKX2.1 (Panel A) and FOXA1 (Panel B) in response to TGF-beta in MLE15 cells. TGF-beta-treated MLE15 nuclear extracts were immunoprecipitated with either anti-NKX2.1 or anti-FOXA1 antibodies and specific regions of the SpB promoter (Please see Materials and Methods section) were analyzed by PCR. Arrows indicate the PCR products. Lanes 1 are molecular weight markers. Representative results from two independent experiments are shown.
###end p 46
###begin p 47
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
Chromatin immunoprecipitation (ChIP) analysis of SpB promoter occupancy for NKX2.1 (Panel A) and FOXA1 (Panel B) in response to TGF-beta in MLE15 cells. TGF-beta-treated MLE15 nuclear extracts were immunoprecipitated with either anti-NKX2.1 or anti-FOXA1 antibodies and specific regions of the SpB promoter (Please see Materials and Methods section) were analyzed by PCR. Arrows indicate the PCR products. Lanes 1 are molecular weight markers. Representative results from two independent experiments are shown.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 101 103 101 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp</italic>
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 611 621 611 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 611 621 <span type="species:ncbi:7227">Drosophila</span>
###xml 626 633 <span type="species:ncbi:8355">Xenopus</span>
The purpose of the current study was to elucidate the mechanisms of TGF-beta-induced, SMAD3-mediated SpB gene repression. We found robust interactions between SMAD3 and two lung-enriched transcription factors, NKX2.1 and FOXA1, both of which are known positive regulators of SpB gene expression (12). The sites of interactions with SMAD3 were identified as the NH2- and COOH-terminal domains of NKX2.1 and principally the winged helix DNA-binding domain of FOXA1. SMAD3 interacted with these proteins through its MAD homology domains MH1 and MH2. Although interactions between SMADs and homeodomain proteins of Drosophila and Xenopus have been reported (19), NKX2.1 is the first mammalian member of this family whose interactions with SMAD3 result in repression of gene expression.
###end p 49
###begin p 50
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad2</italic>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad3</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad3</italic>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 600 603 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
SMADs are intracellular effectors of TGF-beta signaling (1,20). In the lung, TGF-beta/SMAD signaling figures importantly in normal development as well as disease (5,7,21). In addition to activating batteries of genes (e.g. fibronectin, collagen), TGF-beta also represses a number of genes including SpB (19). Although TGF-beta signaling is mediated through both Smad2 and Smad3, to date, in the handful of reported studies in which TGF-beta acts as an inhibitor, Smad3 has been identified as the key mediating mechanism (19). Consistent with these studies, we found SMAD3 to mediate TGF-beta-induced SpB gene repression in lung epithelial cell lines (14).
###end p 50
###begin p 51
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 209 218 209 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figures 5</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1230 1232 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
SMAD3 is composed of two conserved functional domains, the NH2-terminal MH1 and the COOH-terminal MH2 domains, separated by a non-conserved linker domain (LNKR). In the current study, the two-hybrid assays in Figures 5 and 6 identified both MH1 and MH2 domains of SMAD3 as sites of interaction with NKX2.1 and FOXA1, respectively. These results were further verified by the EMSA studies shown in the same Figures (Panels B). Consistent with the two-hybrid assay results, only GST-fused SMAD3, MH1 and MH2 domains and not LNKR inhibited FOXA1 and NKX2.1 DNA binding. The MH1 domain is involved in DNA binding and nuclear translocation but also negatively regulates the functions of the MH2 domain (22,23). The MH2 domain is critical for homo- and hetero-oligomerization of SMADs, as well as the recognition and phosphorylation by type I receptors (1,20). Interactions between transcription factors and SMAD3 through the MH2 or MH1 domains have been reported (19). By far the majority of the reported cases lead to cooperativity and positive regulation of gene expression by TGF-beta. In the few cases in which TGF-beta, through SMAD3 represses gene expression, the sites of interaction were localized to either MH1 or MH2 domains (19).
###end p 51
###begin p 52
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 455 463 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 674 682 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 941 944 941 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
We also determined the specific domains of NKX2.1 and FOXA1 with which SMAD3 interacts. The sites of interaction with SMAD3 were found to be localized to the NH2- and COOH-terminal domains of NKX2.1. Little to no interaction was observed with the NKX2.1 HD domain. Both NH2- and COOH-terminal domains of NKX2.1 have been found to affect transactivation function of NKX2.1 in target gene transcription (24). The results of the mammalian two-hybrid assays (Figure 4) are consistent with the latter findings. These domains alone were able to render transactivation function to the GAL4 DNA-binding domain and activate transcription from the GAL4-responsive reporter with VP16 (Figure 3). The HD of NKX2.1 had no transactivation function. Despite these observations, interactions of SMAD3 with NKX2.1 resulted in an overall reduction of DNA-binding affinity, as assessed by EMSA in Figure 2. Thus, TGF-beta-induced, SMAD3-mediated repression of SpB may affect not only DNA binding, but also transactivation function of NKX2.1.
###end p 52
###begin p 53
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
FOXA1and FOXA2 proteins share 93% amino acid homology in the winged helix DNA-binding domain and bind to the same DNA consensus sequences (18). The winged helix DNA-binding domain is the site of protein-DNA interactions and may also contain the nuclear localization signal (25). The FOXA proteins also include conserved NH2- and COOH-terminal transcriptional activation domains that are involved in protein-protein interactions (26). Regions II and III sequences within the COOH-terminal domain are essential in transcriptional activation (25,27). In the current study, the DNA binding, winged helix domain of FOXA1 was found to be the principal site of interaction with SMAD3. No statistically significant interaction was measurable between SMAD3 and either the COOH- or NH2-terminal domains of FOXA1. Interaction with SMAD3 reduced the DNA-binding affinity of FOXA1 for its target sequences on the SpB promoter. Interactions between other forkhead/winged helix family members, FOXH1 and FOXO with both SMAD2 and SMAD3 have also been documented, although the sites of interaction remain unknown (28,29).
###end p 53
###begin p 54
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 222 230 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 732 741 732 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
To examine the in vivo relevance of our findings, we used two approaches. First, using antibodies to each of the three proteins, we showed that complexes consisting of NKX2.1, FOXA1 and SMAD3 can be co-immunoprecipitated (Figure 7). However, the antibodies failed to demonstrate direct NKX2.1-SMAD3 interactions by co-IP. We propose that this may be due to specific intrinsic properties of the antibodies used. An alternative conclusion is that physical interactions between SMAD3 and NKX2.1 occur only through FOXA1. This possibility however is unlikely in the face of the internally consistent data from the stringent analyses conducted in multiple two-hybrid and EMSA assays with full length and fragments of all three proteins (Figures 1, 3 and 5). These latter studies firmly established direct and robust physical interactions between the COOH- and NH2-domains of NKX2.1 and SMAD3.
###end p 54
###begin p 55
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 708 711 708 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 969 977 969 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 1472 1474 1472 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1477 1486 1477 1486 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 9.</label>
###xml 1568 1569 1568 1569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1700 1703 1700 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1715 1716 1715 1716 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1856 1859 1856 1859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1949 1952 1949 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 1486 1969 1486 1969 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56">A hypothetical model of DNA-independent inhibition of NKX2.1 and FOXA1 by SMAD3. (<bold>A</bold>) In the absence of TGF-beta treatment, NKX2.1 and FOXA1 can readily bind to their cognate sites and activate transcription of the <italic>SpB</italic> promoter. (<bold>B</bold>) Treatment with TGF-beta activates SMAD3, which in turn binds through its MH domains to NKX2.1 and FOXA1 and prevents their binding to the <italic>SpB</italic> promoter. Factors I and II represent other transcription, or co-factors participating in <italic>SpB</italic> gene activation.</p>
###xml 1486 1969 1486 1969 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="56">A hypothetical model of DNA-independent inhibition of NKX2.1 and FOXA1 by SMAD3. (<bold>A</bold>) In the absence of TGF-beta treatment, NKX2.1 and FOXA1 can readily bind to their cognate sites and activate transcription of the <italic>SpB</italic> promoter. (<bold>B</bold>) Treatment with TGF-beta activates SMAD3, which in turn binds through its MH domains to NKX2.1 and FOXA1 and prevents their binding to the <italic>SpB</italic> promoter. Factors I and II represent other transcription, or co-factors participating in <italic>SpB</italic> gene activation.</p></caption>
###xml 1969 1969 1969 1969 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm871f9"/>
###xml 1477 1969 1477 1969 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F9" position="float"><label>Figure 9.</label><caption><p textid="56">A hypothetical model of DNA-independent inhibition of NKX2.1 and FOXA1 by SMAD3. (<bold>A</bold>) In the absence of TGF-beta treatment, NKX2.1 and FOXA1 can readily bind to their cognate sites and activate transcription of the <italic>SpB</italic> promoter. (<bold>B</bold>) Treatment with TGF-beta activates SMAD3, which in turn binds through its MH domains to NKX2.1 and FOXA1 and prevents their binding to the <italic>SpB</italic> promoter. Factors I and II represent other transcription, or co-factors participating in <italic>SpB</italic> gene activation.</p></caption><graphic xlink:href="gkm871f9"/></fig>
In a second approach, ChIP analysis showed that TGF-beta decreased promoter occupancy on the SpB gene for both NKX2.1 and FOXA1, suggesting that TGF-beta signaling, through SMAD3 destabilizes the binding of NKX2.1 and FOXA1 to their target DNA sites. A number of mechanisms may be invoked to explain the latter findings. The possibility that SMAD3 may bind and displace NKX2.1 or FOXA1 (competitive inhibition) does not appear likely for two reasons: First, EMSA analysis has failed to identify SMAD3 as a component of nucleoprotein complexes found on the SpB promoter (data not shown). Second, and consistent with the latter, a SMAD3 mutant lacking the DNA-binding domain is equally competent in inhibiting SpB transcription as the wild-type protein (14). Therefore, we favor a model in which interactions between SMAD3 and either NKX2.1 or FOXA1 occurs independently of the DNA thereby preventing the binding of the latter transcription factors to their target site (Figure 9). Although examples of TGF-beta-induced, SMAD3-mediated gene repression are few, a number of findings are consistent with the results of our study in this report. For example, TGF-beta-inhibition of myogenic differentiation is mediated by SMAD3 interaction with MyoD and myogenin. SMAD3 interacts directly with the HLH domains of MyoD or myogenin and interferes with heterodimerization of the latter with their obligatory partner E12/47, thus decreasing their binding to their DNA target site (30). Figure 9.A hypothetical model of DNA-independent inhibition of NKX2.1 and FOXA1 by SMAD3. (A) In the absence of TGF-beta treatment, NKX2.1 and FOXA1 can readily bind to their cognate sites and activate transcription of the SpB promoter. (B) Treatment with TGF-beta activates SMAD3, which in turn binds through its MH domains to NKX2.1 and FOXA1 and prevents their binding to the SpB promoter. Factors I and II represent other transcription, or co-factors participating in SpB gene activation.
###end p 55
###begin p 56
###xml 82 83 82 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 229 230 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
###xml 463 466 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SpB</italic>
A hypothetical model of DNA-independent inhibition of NKX2.1 and FOXA1 by SMAD3. (A) In the absence of TGF-beta treatment, NKX2.1 and FOXA1 can readily bind to their cognate sites and activate transcription of the SpB promoter. (B) Treatment with TGF-beta activates SMAD3, which in turn binds through its MH domains to NKX2.1 and FOXA1 and prevents their binding to the SpB promoter. Factors I and II represent other transcription, or co-factors participating in SpB gene activation.
###end p 56
###begin p 57
TGF-beta signaling is crucial during normal lung development and maintenance of homeostasis in postnatal life. In addition, many injuries to the lung are characterized by dysregulated TGF-beta signaling. The impact of TGF-beta is manifested in a variety of ways that range from interstitial fibrosis to interruption of alveolar development. Although the overall pathway of TGF-beta signaling may appear simple, physical and functional interactions between its components, such as SMAD3 and other key transcriptional regulators, such as NKX2.1 provide the means for a profound degree of signaling specificity and versatility. Undoubtedly, characterization of the interactions between SMAD3 and NKX2.1 or FOXA1 will aid our understanding of the specificity with which TGF-beta signaling functions in various physiological contexts and therefore its impact on both normal and pathological processes.
###end p 57
###begin title 58
ACKNOWLEDGEMENT
###end title 58
###begin p 59
Research supported by NIH (NHLBI) and the Hastings Foundation. Funding to pay the Open Access publication charges for this article was provided by NIH (NHLBI).
###end p 59
###begin p 60
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
Mechanisms of TGF-beta signaling from cell membrane to the nucleus
###end article-title 62
###begin article-title 63
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice
###end article-title 63
###begin article-title 64
Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency
###end article-title 64
###begin article-title 65
Partial SP-B deficiency perturbs lung function and causes air space abnormalities
###end article-title 65
###begin article-title 66
###xml 145 149 <span type="species:ncbi:10116">rats</span>
Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats
###end article-title 66
###begin article-title 67
Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis
###end article-title 67
###begin article-title 68
Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation
###end article-title 68
###begin article-title 69
###xml 94 99 <span type="species:ncbi:9606">human</span>
TGF-beta1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung
###end article-title 69
###begin article-title 70
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos
###end article-title 70
###begin article-title 71
TAZ interacts with TTF-1 and regulates expression of surfactant protein-C
###end article-title 71
###begin article-title 72
Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription
###end article-title 72
###begin article-title 73
The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis
###end article-title 73
###begin article-title 74
Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis
###end article-title 74
###begin article-title 75
Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors
###end article-title 75
###begin article-title 76
Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein
###end article-title 76
###begin article-title 77
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Differential regulation of rat aquaporin-5 promoter/enhancer activities in lung and salivary epithelial cells
###end article-title 77
###begin article-title 78
The TTF-1/TAP26 complex differentially modulates surfactant protein-B (SP-B) and -C (SP-C) promoters in lung cells
###end article-title 78
###begin article-title 79
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Transcription factors in mouse lung development and function
###end article-title 79
###begin article-title 80
Specificity and versatility in tgf-beta signaling through Smads
###end article-title 80
###begin article-title 81
Smad-dependent and Smad-independent pathways in TGF-beta family signaling
###end article-title 81
###begin article-title 82
###xml 31 46 <span type="species:ncbi:10090">transgenic mice</span>
Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene
###end article-title 82
###begin article-title 83
Transforming growth factor-beta induces nuclear import of Smad3 in an importin- beta1 and Ran-dependent manner
###end article-title 83
###begin article-title 84
A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation
###end article-title 84
###begin article-title 85
Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1
###end article-title 85
###begin article-title 86
Analysis of HNF-3 protein domains required for transcriptional activation and nuclear targeting
###end article-title 86
###begin article-title 87
Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4
###end article-title 87
###begin article-title 88
###xml 122 132 <span type="species:ncbi:7227">Drosophila</span>
Hepatocyte nuclear factor 3 contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein
###end article-title 88
###begin article-title 89
Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage
###end article-title 89
###begin article-title 90
Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif
###end article-title 90
###begin article-title 91
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human Mad protein acting as a BMP-regulated transcriptional activator
###end article-title 91

